Table 1.
Subjects’ characteristics of sarcoma cases and healthy controls retrospectively enrolled in this study
| Characteristic | Controls (n = 610) | Cases (n = 162) | Liposarcoma (n = 93, 57.4%) | Leiomyosarcoma (n = 69, 42.6%) |
|---|---|---|---|---|
| Mean age, years (st.dev.) | 48.6 (14.8) | 60.0 (14.0) | 59.8 (13.3) | 60.2 (14.9) |
| Gender, n (%) | ||||
| Male | 336 (55.2) | 95 (58.6) | 65 (69.9) | 30 (43.5) |
| Female | 273 (44.8) | 67 (41.4) | 28 (30.1) | 39 (56.5) |
| Source of controls, n (%) | ||||
| Hospital | 340 (55.7) | |||
| Population | 270 (44.3) | |||
| Patient status, n (%) | ||||
| Alive | 89 (54.9) | 66 (71.0) | 23 (33.3) | |
| Deceased | 73 (45.1) | 27 (29.0) | 46 (66.7) | |
| Median survival, months (min, max) | 79.0 (1.0, 366.0) | 91.5 (2.0, 366.0) | 42.0 (1.0, 196.0) | |
| Tumoral stage, n (%) | ||||
| I | 37 (23.0) | 23 (25.0) | 14 (20.3) | |
| II | 54 (33.5) | 36 (39.1) | 18 (26.1) | |
| III | 55 (34.2) | 29 (31.5) | 26 (37.7) | |
| IV | 15 (9.3) | 4 (4.3) | 11 (15.9) | |